AlloSource Launches Allomend Extra-Large Acellular Dermal Matrix

The new dermal graft has the largest footprint within the AlloMend product line to support demanding soft tissue applications in plastic and reconstructive surgery

Posted: October 27, 2021 at 2:34 PM EDT

CENTENARY, Col., October 27, 2021 / PRNewswire / – AlloSource®, one of the largest allograft providers in the United States creating innovative cell and tissue products to help surgeons care for their patients, today announced the launch of AlloMend® Extra Large (XL) Acellular Dermal Matrix (ADM), the newest addition to the AlloMend product line.

New AlloMend Extra Large Acellular Dermal Matrix from AlloSource

AlloMend XL Acellular Dermal Matrix is ​​AlloSource’s largest dermal graft for demanding soft tissue applications.

AlloMend XL ADM is the company’s largest skin transplant. It is available in mesh and non-mesh varieties with a 320cm footprint2 (16cm x 20cm) for use in demanding soft tissue applications. The flexible and pliable material provides the desired handling characteristics allowing precise placement.

“Based on the 27 years of AlloSource skin graft manufacturing, we have seen surgeons move to new reconstructive techniques, which require larger dermal grafts for one-piece coverage,” said Dr. . Ross wilkins, Senior Medical Director of AlloSource. “AlloMend XL was created to help surgeons provide better options for their patient’s outcomes. “

Specially meshed AlloMend XL ADM features a 1cm non-mesh border for safe and easy suturing. In addition, the mesh allows for expansion of the graft to provide greater adaptability in reconstruction procedures. The increased surface area assists in potentially faster incorporation and allows for increased drainage of fluids, potentially protecting against seroma formation.

The entire AlloMend product line is treated with AlloSource’s exclusive DermaTrueâ„¢ Decellularization The process of removing cellular debris (including DNA, RNA, proteins, and antigens) making tissue cell-free. In addition, it is sterilized with e-beam technology up to a sterility assurance level (SAL) of 10-6 to minimize the risk of infection, while avoiding damage to the allograft tissue.

Visit us at Plastic Surgery The Meeting booth # 319 to learn more about AlloSource’s extra-large acellular dermal solutions, or to order AlloMend or explore other shapes and sizes within the product line, visit

About AlloSource
Founded in 1994, AlloSource is a leading nonprofit in providing allografts that maximize tissue donation to help surgeons heal their patients. The company has grown into one of the largest tissue networks in the country, creating more than 200 types of precise bone, skin and soft tissue allografts for use in a range of life-enhancing and life-enhancing medical procedures. As a leading manufacturer of cartilage tissue for joint repair and skin allografts to help heal severe burns, AlloSource products link proven allograft science with cutting-edge cell technology. The company is accredited by the American Association of Tissue Banks and is headquartered in Centenary, CO. For more information, please visit

Media contact
Cindy mason
720. 873. 4744
[email protected]

(PRNewsfoto / AlloSource)
(PRNewsfoto / AlloSource)

View original content to download multimedia:

SOURCE AlloSource

The above press release has been provided courtesy of PRNewswire. The views, opinions and statements contained in the press release are not endorsed by Gray Media Group and do not necessarily state or reflect those of Gray Media Group, Inc.

About Florence L. Silvia

Check Also

Risks to shareholder returns are high at these prices for Golden Matrix Group, Inc. (NASDAQ: GMGI)

Golden Matrix Group, Inc. (NASDAQ:GMGI) a price/earnings ratio (or “P/E”) of 58.5x could give the …

Leave a Reply

Your email address will not be published.